SHINE Technologies logo

SHINE Technologies, LLC

Biotechnology

SHINE Technologies Stock

SHINE Technologies specializes in the field of nuclear technology, particularly focusing on the production of medical isotopes. The company uses a unique, proprietary fusion technology to produce isotopes like Molybdenum-99, which are crucial for medical imaging procedures in healthcare. SHINE Technologies aims to create a reliable, environmentally friendly source of medical isotopes, contributing significantly to global health by aiding in the diagnosis of heart disease, cancer, and other major health conditions.

Management Team

Greg Piefer Founder and CEO
Todd Asmuth President and Chief Strategy Officer
Harrie Buurlage Chief Commercial Officer of Isotopes
Jessica Giffey Chief Operating Officer, Systems and Therapeutics
Chris Lee Chief Financial Officer
Ben Pratt Chief People Officer
Ross Rader Chief Technology Officer

Funding Information